YD Bio (NASDAQ:YDES) Shares Gap Up – Here’s What Happened

Shares of YD Bio Limited (NASDAQ:YDES) gapped up before the market opened on Friday . The stock had previously closed at $9.03, but opened at $9.46. YD Bio shares last traded at $9.20, with a volume of 6,447 shares traded.

Analyst Upgrades and Downgrades

YDES has been the subject of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. Wall Street Zen raised YD Bio from a “sell” rating to a “hold” rating in a research report on Saturday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.

YD Bio Price Performance

The company’s 50-day moving average price is $11.05.

Institutional Inflows and Outflows

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC lifted its holdings in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 as of its most recent SEC filing.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.